Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: Topographical evaluation of the IGF-2/IGFBP-2 and IGFBP-3 interface

被引:11
作者
Robinson, SA
Rosenzweig, SA
机构
[1] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA
关键词
D O I
10.1021/bi049082k
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the insulin-like growth factor-1 (IGF)-1 receptor signaling pathways by IGF-1 and IGF-2 results in mitogenic and anabolic effects. The bioavailability of the IGFs is regulated by six soluble binding proteins, the insulin-like growth factor binding proteins (IGFBPs), which bind with similar to0.1 nM affinity to the IGFs and often serve as endogenous antagonists of IGF action. To identify key domains of IGF-1 involved in the interaction with IGFBP-2 and IGFBP-3, we employed IGF-1 selectively biotinylated on residues Gly 1, Lys 27, Lys 65, and Lys 68. All monobiotinylated species of IGF-1 exhibited high affinity (similar to0.1-0.2 nM) for IGFBP-2 and IGFBP-3 in solid-phase-binding assays. However, different labeling intensities were observed in ligand blot analysis of IGFBP-2 and IGFBP-3. The N-epsilonLys65/68(biotin)-IGF-1 (N-epsilonLys65/68b-IGF-1) probe exhibited the highest signal intensity, while N-alphaGly1b-IGF-1 and N-epsilonLys27b-IGF-1 demonstrated significantly lower signals. When taken together, these results suggest that, once bound to IGFBP-2 or IGFBP-3, the biotin moieties of N-alphaGly1b-IGF-1 and N-epsilonLys27b-IGF-1 are inaccessible to NeutrAvidin-peroxidase, the secondary binding component. Ligand blots using IGF-1 derivatized with a long chain form of the N-hydroxysuccinimide biotin (NHS-biotin) to yield N-alphaGly1(LC-biotin)-IGF-1 and N-epsilonFLys27(LC-biotin)-IGF-1 demonstrated increased signal intensity compared with their NHS-biotin counterparts. In BIAcore analysis, IGFBP-2 and IGFBP-3 bound only to the N-epsilonLys65/68b-IGF-1-coated flowcell of a biosensor chip, confirming the inaccessibility of Gly 1 and Lys 27 when IGF-1 is bound to IGFBP-2 and IGFBP-3. These data confirm the involvement of the IGFBP-binding domain on IGF-1 in binding to IGFBP-2 and IGFBP-3 and support involvement of the IGF-1R-binding domain in IGFBP binding.
引用
收藏
页码:11533 / 11545
页数:13
相关论文
共 60 条
[1]   BLOCKADE OF THE TYPE-I SOMATOMEDIN RECEPTOR INHIBITS GROWTH OF HUMAN-BREAST CANCER-CELLS IN ATHYMIC MICE [J].
ARTEAGA, CL ;
KITTEN, LJ ;
CORONADO, EB ;
JACOBS, S ;
KULL, FC ;
ALLRED, DC ;
OSBORNE, CK .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1418-1423
[2]   A KEY FUNCTIONAL-ROLE FOR THE INSULIN-LIKE GROWTH FACTOR-I N-TERMINAL PENTAPEPTIDE [J].
BAGLEY, CJ ;
MAY, BL ;
SZABO, L ;
MCNAMARA, PJ ;
ROSS, M ;
FRANCIS, GL ;
BALLARD, FJ ;
WALLACE, JC .
BIOCHEMICAL JOURNAL, 1989, 259 (03) :665-671
[3]  
BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
[4]  
BAYNE ML, 1988, J BIOL CHEM, V263, P6233
[5]   INSULIN-LIKE GROWTH-FACTOR - MODEL FOR TERTIARY STRUCTURE ACCOUNTING FOR IMMUNOREACTIVITY AND RECEPTOR-BINDING [J].
BLUNDELL, TL ;
BEDARKAR, S ;
RINDERKNECHT, E ;
HUMBEL, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :180-184
[6]   MUTATIONS IN THE C-TERMINAL PART OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEIN-1 RESULT IN DIMER FORMATION AND LOSS OF IGF BINDING-CAPACITY [J].
BRINKMAN, A ;
KORTLEVE, DJ ;
ZWARTHOFF, EC ;
DROP, SLS .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (07) :987-994
[7]   SITE-DIRECTED MUTAGENESIS OF THE N-TERMINAL REGION OF IGF BINDING PROTEIN-1 - ANALYSIS OF IGF BINDING CAPABILITY [J].
BRINKMAN, A ;
KORTLEVE, DJ ;
SCHULLER, AGP ;
ZWARTHOFF, EC ;
DROP, SLS .
FEBS LETTERS, 1991, 291 (02) :264-268
[8]   Structural origins of the functional divergence of human insulin-like growth factor-I and insulin [J].
Brzozowski, AM ;
Dodson, EJ ;
Dodson, GG ;
Murshudov, GN ;
Verma, C ;
Turkenburg, JP ;
de Bree, FM ;
Dauter, Z .
BIOCHEMISTRY, 2002, 41 (30) :9389-9397
[9]   BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains [J].
Carrick, FE ;
Forbes, BE ;
Wallace, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :27120-27128
[10]   MUTANTS OF HUMAN INSULIN-LIKE GROWTH FACTOR-I WITH REDUCED AFFINITY FOR THE TYPE-1 INSULIN-LIKE GROWTH-FACTOR RECEPTOR [J].
CASCIERI, MA ;
CHICCHI, GG ;
APPLEBAUM, J ;
HAYES, NS ;
GREEN, BG ;
BAYNE, ML .
BIOCHEMISTRY, 1988, 27 (09) :3229-3233